Xylem Inc. $XYL Shares Bought by Bank of Nova Scotia

Bank of Nova Scotia raised its holdings in Xylem Inc. (NYSE:XYLFree Report) by 111.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 97,027 shares of the industrial products company’s stock after acquiring an additional 51,139 shares during the period. Bank of Nova Scotia’s holdings in Xylem were worth $11,595,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in XYL. Wexford Capital LP acquired a new stake in Xylem during the third quarter worth about $27,000. Commonwealth Retirement Investments LLC purchased a new position in Xylem during the fourth quarter valued at approximately $27,000. Entrust Financial LLC acquired a new position in Xylem in the fourth quarter valued at approximately $45,000. FWL Investment Management LLC acquired a new stake in Xylem during the second quarter valued at $43,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Xylem during the fourth quarter valued at $45,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Price Performance

Shares of NYSE XYL opened at $119.66 on Monday. The firm has a 50-day simple moving average of $114.04 and a 200-day simple moving average of $122.70. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $28.44 billion, a price-to-earnings ratio of 29.77, a price-to-earnings-growth ratio of 1.70 and a beta of 1.03. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. During the same period in the previous year, the business posted $1.03 earnings per share. Xylem’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, equities analysts predict that Xylem Inc. will post 5.52 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s payout ratio is currently 42.79%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on XYL shares. Citigroup lowered their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. UBS Group raised their price objective on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Stifel Nicolaus cut their price objective on Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research report on Monday, July 20th. Barclays reduced their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada increased their target price on Xylem from $157.00 to $159.00 and gave the company an “outperform” rating in a research report on Thursday, July 16th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $153.15.

View Our Latest Stock Analysis on XYL

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The stock was bought at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is owned by corporate insiders.

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.